Answers are grounded in this paper and cite their sources.
Background and Aims: Ultrasound-guided ilioinguinal–iliohypogastric nerve block (II–IHNB) provides effective analgesia for inguinal hernia surgery; however, the duration of analgesia with local anaesthetic alone is limited. This study compared dexmedetomidine and magnesium sulphate as adjuvants to ropivacaine for II–IHNB. Methods: In this randomised controlled trial, 120 patients were allocated into three groups ( n = 40 each). Group A received 0.5% ropivacaine, group B received ropivacaine with magnesium sulphate (5 mg/kg), and group C received ropivacaine with dexmedetomidine (1 µg/kg). The primary outcome was time to first rescue analgesia. Secondary outcomes included visual analogue scale (VAS) scores, 24-hour opioid consumption, sedation, haemodynamic parameters, and adverse events. Results: The time to first rescue analgesia was significantly longer in group C than in group A, with a median difference of 1080 min [95% confidence interval (CI): 923–1125 min; P < 0.001]. The total 24-hour opioid consumption was significantly lower in group C than in group A, with a median difference of − 10 morphine milligram equivalents (95% CI: −15 to − 5; P < 0.001). VAS scores at rest and movement were significantly lower in group C at multiple postoperative time points ( P < 0.001). Sedation scores were higher in group C in the immediate postoperative period ( P < 0.001), but no clinically significant respiratory depression occurred. Haemodynamic parameters and the incidence of adverse events remained comparable across groups ( P > 0.05). Conclusion: Dexmedetomidine is superior to magnesium sulphate as an adjuvant to ropivacaine in II–IHNB, providing prolonged analgesia, reduced opioid consumption, and stable haemodynamics with an acceptable sedation profile.
No takes yet. Share an insight, caveat, or question.
Senapati et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: